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OBJECTIVES We sought to describe characteristics and outcome in adults with isolated ventricular
noncompaction (IVNC).
BACKGROUND Isolated ventricular noncompaction is an unclassified cardiomyopathy due to intrauterine
arrest of compaction of the loose interwoven meshwork. Knowledge regarding diagnosis,
morbidity and prognosis is limited.
METHODS Echocardiographic criteria for IVNC include—in the absence of significant heart lesions—
segmental thickening of the left ventricular myocardial wall consisting of two layers: a thin,
compacted epicardial and an extremely thickened endocardial layer with prominent trabecu-
lations and deep recesses. Thirty-four adults (age $16 years, 25 men) fulfilled the diagnostic
criteria and were followed prospectively.
RESULTS At diagnosis, mean age was 42 6 17 years, and 12 patients (35%) were in New York Heart
Association class III/IV. Left ventricular end-diastolic diameter was 65 6 12 mm and
ejection fraction 33 6 13%. Apex and/or midventricular segments of both the inferior and
lateral wall were involved in .80% of patients. Follow-up was 44 6 40 months. Major
complications were heart failure in 18 patients (53%), thromboembolic events in 8 patients
(24%) and ventricular tachycardias in 14 patients (41%). There were 12 deaths: sudden in six,
end-stage heart failure in four and other causes in two patients. Four patients underwent heart
transplantation. Automated cardioverter/defibrillators were implanted in four patients.
CONCLUSIONS Diagnosis of IVNC by echocardiography using strict criteria is feasible. Its mortality and
morbidity are high, including heart failure, thrombo-embolic events and ventricular arrhyth-
mias. Risk stratification includes heart failure therapy, oral anticoagulation, heart transplan-
tation and implantation of an automated defibrillator/cardioverter. As IVNC is a distinct
entity, its classification as a specific cardiomyopathy seems to be more appropriate. (J Am
Coll Cardiol 2000;36:493–500) © 2000 by the American College of Cardiology
Noncompacted myocardium has been categorized as unclas-
sified cardiomyopathy by the World Health Organization in
the recently published report on definition and classification
of cardiomyopathies (1). Noncompacted myocardium was
previously described as persistent intramyocardial sinusoids.
However, the latter are associated with congenital obstruc-
tive lesions of the left or right ventricular outflow tract, such
as pulmonary atresia with intact ventricular septum (2–4).
In these patients, regression of the embryogenic sinusoids is
impaired during ontogenesis by ventricular pressure over-
load that results in deep recesses that communicate with
both the ventricular cavity and the coronary artery system
(3,5,6).
By contrast, isolated ventricular noncompaction (IVNC)
is an idiopathic cardiomyopathy characterized by an altered
structure of the myocardial wall as a result of intrauterine
arrest of compaction of the myocardial fibers in the absence
of any coexisting congenital lesion (7,8). There is continuity
between the left ventricular (LV) cavity and the deep
intratrabecular recesses that are filled with blood from the
ventricular cavity without evidence of communication to the
epicardial coronary artery system (9,10). Thus, the term
“noncompaction” rather than “persistent sinusoids” is more
appropriate for this condition (9,10). Since the original
description, there have been only a few publications of case
reports and small patient series describing predominantly a
pediatric population (9,11–18). Despite an increasing
awareness and interest in this anomaly, however, there is
still little knowledge regarding diagnostic criteria, symptoms
and prognosis of this rare and unique congenital disorder
categorized as unclassified cardiomyopathy (1).
This study was designed to report clinical and echocar-
diographic characteristics and long-term outcome in the
largest-ever described population of adults with IVNC.
METHODS
Diagnostic criteria. In the absence of other congenital or
acquired heart disease, the typical echocardiographic image
of noncompacted myocardium in IVNC is characterized by
an altered structure of the LV myocardium with extremely
thickened, hypokinetic segments consisting of two layers.
There is thin, compacted myocardium on the epicardial side
(epicardial layer) and thicker noncompacted myocardium on
the endocardial side (endocardial layer), resulting in an
extremely thickened ventricular wall. End-systolic thickness
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of both the noncompacted epicardial and the compacted
endocardial layer was measured at the site of maximal
thickness to calculate the ratio of noncompacted/compacted
(N/C). The measurements were taken at end-systole for
best visualization of the two layers. The noncompacted
endocardial layer has to be thicker than the compacted
epicardial layer (ratio of N/C $2) and to consist of: 1)
prominent and excessive trabeculations, and 2) deep recesses
filled with blood from the ventricular cavity visualized on
color Doppler imaging (Fig. 1). We have shown previously
that diagnosis and localization of IVNC by echocardiogra-
phy correspond to the necropsy specimens and to the
findings of explanted hearts (10).
Study population. Between January 1984 and December
1998, 34 adults (age $16 years, 25 men) fulfilled the
diagnostic criteria of IVNC (prevalence of 0.014% in
patients referred to our echocardiography laboratory), and
their data were prospectively entered into the database of
our laboratory. Informed consent was given by all patients.
Data acquisition. Clinical assessment included a detailed
medical history using standardized questionnaires. Medical
records were reviewed. Sudden death was defined as occur-
ring within 1 h of the patient’s usual state of health or as
unwitnessed death during sleep (19). All patients had a
12-lead resting electrocardiogram (ECG) and a complete
two-dimensional Doppler echocardiographic exam as de-
scribed below. Additionally, in 19 patients 24-h Holter
monitoring was performed. Nonsustained ventricular tachy-
cardia was defined as ventricular tachycardia of more than
three premature ventricular contractions lasting up to 30 s.
A ventricular run of more than 30 s was defined as sustained
ventricular tachycardia.
Echocardiography. A complete two-dimensional and
Doppler echocardiographic examination was performed in all
patients according to the recommendations of the American
Society of Echocardiography including two-dimensional
guided M-mode measurements (20–22). Left ventricular ejec-
tion fraction was calculated using the biplane area length
method (23).
The LV wall was divided into nine segments to describe
the location of the noncompacted segments: the whole apex
was one segment (apical segment); at the base and at the
midventricular level, the LV was divided into four segments
each (inferior, lateral, anterior and septal). The four mid-
ventricular segments were localized between the apical
segment and the papillary muscles and the four basal
segments between the papillary muscles and the base.
Diastolic function was assessed as previously described
measuring the LV inflow pattern at the tip of the mitral
valve leaflets and the pulmonary venous flow pattern in the
right lower (or upper) pulmonary vein (24). Using previ-
ously published criteria, diastolic function was graded as
follows: normal or abnormal relaxation, pseudonormal or
restrictive pattern (24).
Follow-up. Prospective clinical follow-up was obtained in
all 34 patients. Freedom from death and heart transplanta-
tion (nonsurvivors) were the combined end points of event-
free survival. Heart transplant recipients were considered
dead at the time of heart transplantation. Out of the 34
patients, serial echocardiographic data were available in 20
patients (59%). No serial echocardiography at our laboratory
was obtained in 10 patients whose follow-up was less than
two years (death, heart transplantation or recent diagnosis)
and in four patients in whom follow-up echocardiography
was performed by their private cardiologist after the diag-
nosis had been established.
Statistical analysis. Descriptive data for continuous vari-
ables are presented as means 6 one standard deviation.
Chi-square analysis or Fisher exact tests were used for
nominal data. Continuous data were compared by the
Mann-Whitney U test or the Wilcoxon rank-sum test.
Probability of the event-free rate for the combined end
point of death or heart transplantation was calculated by the
Kaplan-Meier method of life table estimation. A p value of
,0.05 was considered as statistically significant. Multivar-
iate analysis was not performed, because of the small
number of patients.
RESULTS
Clinical data. Clinical and electrocardiographic character-
istics of the study population are presented in Table 1. The
age range at the time of diagnosis was wide (16–71 years).
Twenty-two patients (65%) were in New York Heart
Association (NYHA) class I or II. Reasons for referral were:
heart failure in 21 patients (62%); uncertain echocardio-
graphic findings in four (12%); palpitations in two (6%);
cardiomegaly, syncopal event, mitral regurgitation, myocar-
ditis or pericarditis (one of each, 3%). One patient was
referred to confirm the diagnosis of IVNC; one daughter of
a patient was screened because of the familial occurrence
risk and was diagnosed to have IVNC. Familial occurrence
of IVNC was present in three families.
Echocardiographic data. Echocardiographic findings at
the time of first presentation are summarized in Table 2.
Left ventricular muscle mass cannot be calculated in pa-
tients with IVNC. An enlarged LV end-diastolic diameter
($60 mm) was present in 22 patients (67%), and reduced
fractional shortening (,29%) in 27 of 33 patients (82%).
Diastolic function could be assessed by echocardiography in
17 patients (50%); it was either not feasible (atrial fibrilla-
tion, tachycardia) or not yet done by Doppler echocardiog-
raphy in the other patients.
Left ventricular thrombi were documented by echocardi-
Abbreviations and Acronyms
ECG 5 electrocardiogram
IVNC 5 isolated ventricular noncompaction
LV 5 left ventricle or left ventricular
NYHA 5 New York Heart Association
N/C 5 noncompacted/compacted
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Figure 1. (A) Apical four-chamber view of a 66-year-old man. There is a thin epicardial layer (thin arrows) and an extremely thickened endocardial layer
with prominent trabeculations and deep recesses (arrowheads). (B) Apical four-chamber view (end-diastolic still frame) of the same patient. There is blood
flow from the ventricular cavity into the deep recesses visualized on color Doppler imaging. (C) Transsectional view from the anterior on the dorsal half
of the heart of a 21-year-old man. There are both numerous trabeculations and deep recesses. Note marked fibroelastosis of the left ventricle. (D)
Transmural, histologic section (hematoxylin and eosin stain). There are both an epicardial (compacted) layer (arrows) and an endocardial (noncompacted)
layer. Note necrosis within the trabeculations (asterisks) as well as in the subendocardial area but not in the epicardial zone (arrowheads). LA 5 left atrium;
LV 5 left ventricle; RA 5 right atrium; RV 5 right ventricle.
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ography in three patients, one of them with a history of
mesenteric infarction.
Localization of noncompacted myocardial segments is
shown in Figure 2. Most commonly, the apical and mid-
ventricular segments of both the inferior and lateral wall
were affected (in more than 80% of patients). Involvement
of the midventricular anterior wall and septum and the basal
segments was much less frequent. Three and more segments
were involved in 27 patients (79%). All noncompacted
segments were hypokinetic. The normally compacted seg-
ments were occasionally also hypokinetic—despite normal
wall thickness—which was reflected by the impaired frac-
tional shortening in 27 patients (82%) consistent with basal
hypokinesia. Left ventricular ejection fraction was ,50% in
24 of 28 patients (86%).
Follow-up data. Duration of follow-up was 44 6 39
months (range: 0.7–139). Mean age at the time of last
follow-up (or before death or heart transplantation) was
46 6 18 years (range: 16–71). Major complications are
presented in Table 3. Heart failure (53%) requiring hospital
admission was the most frequent event. Two patients
presented in cardiogenic shock at the time of diagnosis; one
of them died before transplantation could be attempted.
The other patient was stabilized with medications, remain-
ing in NYHA class II for eight years. Cardiogenic shock
occurred in three other patients who could be medically
stabilized using positive inotropic support in the intensive
care unit.
Eleven thromboembolic events were observed in eight
patients (24%). Eight systemic thromboembolic events oc-
curred in seven patients (21%) including seven cerebrovas-
cular accidents as the most common event in six patients
(one episode of a stroke, six episodes of transient ischemic
attacks); one patient suffered from a mesenteric infarction.
Three episodes of pulmonary embolism were diagnosed in
three patients. Two of the patients with pulmonary embo-
lism also had cerebrovascular events or a mesenteric infarc-
tion, respectively.
Ventricular tachycardias were observed in 14 patients
(41%): there were nonsustained ventricular tachycardias in
11 patients and sustained ventricular tachycardias in three
patients. One patient with sustained ventricular tachycardia
resistant to medical and electrical therapy died within 1 h
after the onset of the arrhythmia. An automated internal
cardioverter/defibrillator was implanted in four patients for
sustained ventricular tachycardia (n 5 2) or a presyncopal
event and inducible ventricular tachycardia by electrophysi-
ologic study (n 5 2). One of these patients died from
recurrent and refractory sustained ventricular tachycardia
despite the implanted cardioverter/defibrillator.
In 20 patients with serial echocardiographic studies, there
was no significant change of LV size or fractional shorten-
ing during follow-up (p 5 ns).
Figure 2. Distribution of segments affected by ventricular noncompaction.
Table 1. Clinical and Electrocardiographic Characteristics in 34
Adults With IVNC at Initial Presentation
Male gender 25 patients (74%)
Age at diagnosis 42 6 17 years
Chest pain 9 patients (26%)
Shortness of breath 27 patients (79%)
NYHA class I/II 22 patients (65%)
class III/IV 12 patients (35%)
Familial occurrence of IVNC 6 patients (18%)
Abnormal ECG 32 patients (94%)
Chronic atrial fibrillation 9 patients (26%)
Right bundle branch block 4 patients (12%)




Wolff Parkinson White syndrome 0 patient (0%)
ECG 5 electrocardiogram; IVNC 5 isolated ventricular noncompaction; NYHA 5
New York Heart Association.
Table 2. Echocardiographic Data at Initial Presentation*
LVEDD 65 6 13 mm (normal: , 60 mm)
Fractional shortening 19 6 10% (normal: 29–46%)
Ejection fraction (n 5 28) 33 6 13% (normal: $ 50%)
Left atrial size 4.4 6 0.9 cm (normal: 1.5–4.0 cm)
Thickness of basal septum 1.0 6 0.2 cm (normal: 0.6–1.2 cm)
Thickness of posterior wall 1.0 6 0.4 cm (normal: 0.6–1.2 cm)
Left ventricular thrombi 3 patients (9%)
Diastolic function (n 5 17)
Impaired relaxation 6 patients (35.5%)
Restrictive pattern 6 patients (35.5%)
Pseudonormal 5 patients (29%)
Normal 0 patient (0%)
*Quantitative M-mode measurements were not available in one patient examined in the intensive care unit.
LVEDD 5 left ventricular end-diastolic diameter.
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Mortality and heart transplantation. Eighteen patients
(53%) were alive at last follow-up, 12 (35%) were dead, and
4 (12%) had undergone heart transplantation because of end
stage heart failure (Table 3). Twelve patients died 42 6 40
months (0.7–105) after diagnosis: sudden death occurred in
six patients with stable NYHA class II (50% of all deaths),
death from end stage heart failure in four (33%) and
arrhythmic, non–sudden death in one (8.5%). Pulmonary
embolism was the cause of death in another patient. Four
patients underwent heart transplantation because of end
stage myocardial failure at 3 to 33 months after diagnosis.
The event-free rate for the combined end point of death or
heart transplantation is shown in Figure 3. The probability
of event-free survival (combined end point for death and
heart transplantation) was 58% at five years. Mean age at
death or heart transplantation was 45 6 17 years (range
19–71).
Echocardiographic diagnosis was confirmed by
pathologic-anatomic examination in nine patients: in five of
them after death, in four of them after heart transplantation.
Autopsy was not performed in seven deceased patients,
because of refusal or death abroad.
Characteristics of survivors and nonsurvivors. The left
ventricular end-diastolic diameter at the time of initial
presentation was significantly larger in nonsurvivors (71 6
9 mm) than it was in survivors (61 6 12 mm; p , 0.005).
New York Heart Association class III/IV (63% vs. 11%, p ,
0.005), chronic atrial fibrillation (50% vs. 6%, p , 0.005)
and bundle branch block (75% vs. 39%, p , 0.045) were
more frequently present in nonsurvivors than in survivors.
There was no significant difference between survivors and
nonsurvivors regarding age at diagnosis, gender, heart fail-
ure requiring hospital admissions, fractional shortening and
the presence of both embolic events and ventricular tachy-
cardia.
DISCUSSION
Isolated ventricular noncompaction is a rare and unique
congenital disorder categorized as unclassified cardiomyop-
athy in 1995 (1). Because of increasing awareness of this
congenital anomaly after the initial publications, and ad-
vances in echocardiographic imaging, several more recent
reports followed the first descriptions (7–18,25,26). Our
series of 34 adults is the largest series so far. Clinical and
echocardiographic characteristics and outcome during long-
term follow-up are reported.
Clinical presentation. At presentation, the most common
reasons for referral were heart failure and uncertain echo-
cardiographic findings. In most patients (94%), the ECG
was abnormal. Although embolic events were frequent
complications, they were never the reason for referral. The
age range at diagnosis or onset of heart failure varied widely.
The only way to diagnose IVNC reliably was by echocar-
diography.
Diagnosis by echocardiography. Isolated ventricular non-
compaction can be easily diagnosed by echocardiography if
the echocardiographer is familiar with this congenital dis-
order and if clear cut diagnostic criteria are used. We have
previously shown that the echocardiographic pattern allows
both correct diagnosis and identification of segments in-
volved in IVNC and there is excellent agreement with the
necropsy findings (10). However, prominent LV trabecula-
tions can be found in up to 68% of healthy hearts (27) and
can be observed in hypertrophic hearts secondary to dilated,
valvular or hypertensive cardiomyopathy. Thus, the differ-
entiation between variants and IVNC may occasionally be
challenging. However, the characteristic discriminating fea-
ture, which is crucial to diagnose IVNC, is the two layered
myocardial wall structure with both a thin epicardial com-
pacted zone and an extremely thickened endocardial non-
compacted zone with deep recesses filled with blood from
the ventricular cavity. Both the epicardial and endocardial
layers of the myocardium in the noncompacted areas are
perfused from the epicardial coronary arteries while the
recesses are filled with blood directly from the LV cavity.
We found the determination of the previously described
X-to-Y ratio between the depth of intertrabecular recesses
Figure 3. Probability of event-free rate for the combined end point of
death or heart transplantation during follow-up.
Table 3. Long-Term Follow-up Data
Number of
Patients
Heart failure requiring hospitalization 18 (53%)
Deaths 12 (35%)
Heart failure 4 (33%)
Sudden cardiac death 6 (50%)
Others* 2 (17%)
Heart transplantation 4 (12%)
Syncope 6 (18%)
NYHA class at last follow-up or before heart
transplantation or death
Class I/II 18 (53%)
Class III/IV 16 (47%)
Ventricular tachycardia 14 (41%)
Thromboembolic events 8 (24%)
Cerebrovascular accident 1 (3%)
Transient ischemic attack 6 (18%)
Mesenteric infarction 1 (3%)
Pulmonary embolism 3 (9%)
*Two other deaths included pulmonary embolism and arrhythmic, nonsudden death.
NYHA 5 New York Heart Association.
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relative to wall thickness helpful, but end-diastolic differ-
entiation between noncompacted and compacted myocar-
dium was often difficult (9). Therefore, we propose to
identify first the segment with maximal wall thickness and
then to assess the end-systolic thickness ratio between the
noncompacted and the compacted layer. A ratio of non-
compacted/compacted $2 is diagnostic for IVNC. In hearts
with prominent trabeculations from other causes, the thick-
ness ratio between trabeculated and normal zones never
reaches the ratio of $2. By contrast to prominent trabecu-
lations secondary to arterial hypertension or valvular disease,
a segmental rather than a diffuse thickening or hypertrophy
is present in patients with IVNC.
Another useful criterion is the location of the prominent
trabeculations in patients with IVNC, which typically is
apical, inferior and lateral and which is different from the
prominent trabeculations found in normal or hypertrophied
hearts. Prominent trabeculations as variants of normal
hearts most frequently (85%) course from the free wall to
the ventricular septum (27).
The right ventricular apex presents often with hypertro-
phic trabeculae separated by fissures, making the differen-
tiation between variants of normal or pathologic patterns
difficult. Thus, we do not attempt to diagnose right ven-
tricular noncompaction as previously reported (10).
Morbidity and mortality. Major morbidity during long-
term follow-up included heart failure, arrhythmias and
thromboembolic events. Heart failure was caused by systolic
and diastolic dysfunction. All our patients in whom diastolic
function was assessed had diastolic dysfunction. Most of our
patients (82%) also had diminished fractional shortening.
Heart failure was the most common cause for hospital
admission; it led to death and/or heart transplantation in
eight patients (24%). The presence of noncompacted myo-
cardium has, therefore, an impact on morbidity comparable
with other cardiomyopathies.
Although depressed LV systolic function was found in
48% of children at initial presentation (13), clinically overt
signs of heart failure were more frequent in our adult
population. However, up to 89% of these children with a
follow-up period longer than 10 years developed reduced
LV function (13). In an older predominantly pediatric
population, heart failure was as common as it was in our
population (9). These observations suggest that IVNC
present at birth is a progressive disorder resulting in systolic
and diastolic heart failure during long-term follow-up, with
a higher prevalence of heart failure in the adult than in the
pediatric population. The cause of progressive myocardial
failure has not yet been elucidated. The hypertrophic
segments are perfused via the epicardial coronary arteries,
which have no continuity to the deep recesses communicat-
ing with the LV cavity. Thickened endocardium and isch-
emic lesions in prominent trabeculae surrounded by the
deep trabecular recesses were documented in histologic
specimens, which may be caused by ischemia (10). Indeed,
restricted myocardial perfusion in areas of IVNC was
demonstrated by positron emission tomography (28). Hy-
pothetically, both morphology and vasomotion of the cor-
onary vessels feeding the hypertrophic segments may be
abnormal with subsequent ischemia. Progressive ischemia
and subsequent scar tissue may be an arrhythmogenic
substrate for ventricular arrhythmias because the well-
defined morphologic substrate of IVNC cannot be consid-
ered inherently arrhythmogenic.
Although IVNC in the basal segments was present only
in a minority of the patients (Fig. 2), fractional shortening
was reduced in 82% of our population as a consequence of
progressive ventricular dilation with subsequent increase in
Table 4. Characteristics of Isolated Ventricular Noncompaction in the Pediatric and
Adult Population
Chin et al.9 Ichida et al.13 Present Study
Number of patients 8 patients 27 patients 34 patients
Men 63% 56% 74%
Facial dysmorphism 38% 33% 0%
Age at diagnosis (median) 7 yrs 5 yrs 40 yrs
Follow-up (median) Up to 5 yrs Up to 17 yrs (6 yrs) Up to 11 yrs (3 yrs)
Bundle branch block 25%* 15% 56%
Wolff Parkinson White syndrome 13% 15% 0%
Ventricular tachycardia 38% 0% 41%
Familial occurrence 50% 44% 18%
Heart failure symptoms 63% 30% 68%
Systemic embolic events 38% 0% 21%
Pulmonary embolism 0% 7% 9%
Ventricular thrombi 25% 0% 9%
Deaths 38% 7% 35%
Heart transplantation 0% 4%¶ 12%
Localization of noncompacted segments
Apex Most prominent 100% 94%
Inferior wall 70% 94%
Lateral wall 41% 100%
*Left ventricular (intraventricular) conduction defects; ¶One patient was a candidate for heart transplantation.
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wall stress, subendocardial ischemia and fibrosis. However,
these hypotheses need further investigation.
The high prevalence of thromboembolic events (24% of
patients) was consistent with a previous report and was
independent of LV size or function (9). The deep recesses
may aggravate the risk of thrombus formation and be an
additional factor for this serious complication. No systemic
embolic events were found in the Japanese children, reflect-
ing a younger and probably healthier population (13). In
Chin’s population, ventricular thrombi and systemic em-
bolic events were even more common than they were in our
population (9). Thus, we recommend oral anticoagulation
for every patient in whom IVNC is diagnosed.
Long-term follow-up showed a high incidence of heart
transplantation and death. Fifty percent of the patients died
suddenly. Heart failure was the second most common cause
of death. “Early” heart transplantation and “early” implan-
tation of an automated cardioverter/defibrillator may be
options for reducing the risk of premature death. We use
this strategy for all of our patients with IVNC, especially for
patients with NYHA class III or IV, atrial fibrillation
and/or severely dilated LVs, which are more common in
nonsurvivors. However, there are no data in this small
population to support this strategy.
Comparison with pediatric population. Our data for
adults and those of the two largest pediatric series so far
published are summarized in Table 4 (9,13). Major discrep-
ancies in the adult population were the lack of facial
dysmorphism and the absence of Wolff Parkinson White
syndrome. This may be explained by a different genetic
background but the same morphologic appearance of the
cardiac anomaly. In some chromosomal abnormalities (i.e.
Xq28-linked noncompaction), prognosis is poor without
survival until adulthood (11). Incomplete screening of the
siblings may be a reason for the lower familial occurrence in
our population. Complete bundle branch block was more
common in adults. Other findings such as heart failure,
ventricular tachycardias, embolic events or predominant
involvement of the apical and inferior segments were com-
parable in adults and in an older pediatric population or
adolescents. Although IVNC is a congenital disorder and
present at birth, its clinical presentation may depend on the
extent of noncompacted segments. Furthermore, the sever-
ity of this anomaly may progress during follow-up as a result
of abnormal morphology and vasomotion of the vessels,
with subsequent ischemia and progressive ventricular dila-
tion as already hypothesized.
Study limitations. Our population consisted of patients
referred to a tertiary care center because of severe heart
failure or uncertain echocardiographic findings. Thus, there
is selection bias in this population representing a highly
selected group of mainly symptomatic patients. However,
the true prevalence of this disorder in an unselected group
consisting of both asymptomatic and symptomatic patients
is not known, and the natural course of IVNC needs to be
further elucidated.
Conclusions. This largest series of adults with IVNC to
date confirms the high prevalence of heart failure, embolic
events, ventricular arrhythmias and the poor prognosis in
symptomatic patients. Anticoagulants should be adminis-
tered independent of ventricular function to prevent embolic
complications. Isolated ventricular noncompaction has a
characteristic clinical, echocardiographic and pathologic
pattern representing a pathologic anatomic entity distin-
guishable from other cardiomyopathies. Thus, IVNC
should be classified as a specific cardiomyopathy comparable
with other rare, distinct cardiomyopathies (e.g., arrhythmo-
genic right ventricular cardiomyopathy) to make the physi-
cian more familiar with this congenital disorder and its
clear-cut diagnostic criteria.
Echocardiography is the method of choice to diagnose
IVNC. There is a two-layered structure of the myocardial
wall consisting of a thin compacted epicardial layer and a
thick noncompacted endocardial layer with prominent tra-
beculations and deep recesses. Because of the risk of familial
occurrence, first-degree relatives should be screened by
echocardiography to identify asymptomatic patients. As
physicians are becoming more aware of this rare disorder,
previously missed patients may be diagnosed, and the true
prevalence and natural course of IVNC will be better
elucidated and understood in the future.
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